NEW YORK – Many US veterans from across the country with advanced cancers are treated at small community centers or in rural settings that may not seem especially conducive to precision oncology approaches.

But researchers with the Department of Veterans Affairs, Duke University Medical Center, Argonne National Laboratory, and Duke Cancer Institute have demonstrated that it is feasible to systematically find and interpret actionable tumor mutations in this large patient population, even within a cost-conscious government health system.